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A new series of R1,R2-thieno[2,3-d]pyrimidine-4(3H)-one, thione and selenone derivatives have been synthesized; 
the reaction of alkylation of the compounds obtained has been studied. Their structures have been confirmed 
by the NMR 1H and mass spectra, and elemental analysis. The antibacterial and antifungal activities in vitro 
against three bacterial and two fungal pathogens have been revealed using the stiff plate agar diffusion method 
and the serial dilution method. The minimal bactericidal, fungicidal and bacteriostatic concentrations have been 
obtained. The pharmacological screening has shown that some of the compounds obtained possess a good 
antimicrobial activity. The culture of S.aureus. appeared to be the most sensitive to compound 10a. The best 
fungistatic indicators against A.niger have been found for compounds 4a and 9a.
СИНТЕЗ, РЕАКЦІЙНА ЗДАТНІСТЬ ТА АНТИМІКРОБНА АКТИВНІСТЬ ЗАМІЩЕНИХ ТІЄНО[2,3-d]ПІРИМІДИН-
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Синтезовано ряд нових похідних R1,R2-тієно[2,3-d]піримідин-4(3Н)-онів, тіонів і селенонів та вивчено 
реакцію алкілування отриманих продуктів. Структури отриманих продуктів встановлені за допомо-
гою даних ЯМР 1Н та мас-спектрів і даних елементного аналізу. Антибактеріальну і фунгістатичну 
активність in vitro проти 3 культур бактерій і двох видів грибів було встановлено за допомогою ме-
тоду дифузії речовини в агар і методу серійних розведень. Були визначені мінімальні концентрації бак-
теріальної, фунгістатичної і бактеріостатичної активності. Фармакологічне дослідження підтверди-
ло, що деякі з отриманих продуктів проявляють добру антимікробну активність. Культура бактерії 
S.aureus. найбільш чутлива до сполуки 10а. Найкращі фунгістатичні показники проти цвільового гриба 
A.niger виявлені для сполук 4а і 9а. 
СИНТЕЗ, РЕАКЦИОННАЯ СПОСОБНОСТЬ И АНТИМИКРОБНАЯ АКТИВНОСТЬ ЗАМЕЩЕННЫХ ТИЕНО[2,3-d]
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Синтезирован ряд новых производных R1,R2-тиено[2,3-d]пиримидин-4(3Н)-онов, тионов и селенонов, изуче-
на реакция алкилирования полученных соединений. Структуры полученных соединений установлены 
с помощью данных ЯМР 1Н и масс-спектров, а также данных элементного анализа. Антибактериальная и 
фунгистатическая активность in vitro против трёх видов бактерий и двух видов грибов была обнару-
жена с помощью метода диффузии вещества в агар и метода серийного разведения. Определены ми-
нимальные концентрации бактериальной, фунгицидной и бактериостатической активности. Фарма- 
кологическое исследование подтвердило, что некоторые из полученных продуктов проявляют хорошую 
антимикробную активность. Культура бактерии S.aureus наиболее чувствительна к соединению 10а.  
Наилучшие фунгистатические показатели против цвелевого гриба A.niger определены для соедине-
ний 4а и 9а.  Thieno[2,3-d]pyrimidines are of great interest in pharmaceutical industry due to the potent physiologi-cal properties such as blood platelet aggregation in-
hibition, the antiviral and anti-inflammatory activity [1-3]. Molecular docking also shows that thieno[2,3-d]pyrimidines reveal the increased activity as inhibi-tors for PARP-1 (poly(ADP-ribose)-polymerase-1) [4]. Although the synthesis of thieno[2,3-d]pyrimidines has attracted much attention in organic synthesis, so far 
only few methods have been reported for the synthesis of benzothieno[2,3-d]pyrimidines [5, 6]. Moreover, thieno[2,3-d]pyrimidines containing active functio-nal groups are especially of great interest. The pres-ence of different groups (R=O, S, Se) in position 4 of thieno[2,3-d]pyrimidine causes the possibility of 
further structural modification by different reagents. Thus, as part of our ongoing research in discovery of new biologically active thienopyrimidine deriva-
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le and highly efficient methods of the synthesis of R1,R2-thieno[2,3-d]pyrimidines 3a-c and 4a-c, the study their alkylation and antibacterial properties depending on atom in position 4 of the heterocycle.  The synthesis strategy of the starting thieno[2,3-d]pyrimidin-4(3H)-ones 1a-c was based on the classical Hewald reaction reported in the literature [7, 8]. Treat-ment of ketones with ethyl 2-cyanoacetate gave the corresponding 2-aminothiophene carboxylic esters that, in turn, gave compounds 1a-c upon refluxing in formamide. Further compounds 1a-c were con-verted into the corresponding 4-chlorothieno[2.3-d] pyrimidines 2a-c under the action of phosphorus oxychloride and dimethylaniline. Thieno[2,3-d]py-rimidine-4(3H)-thiones 3a-c and benzothieno[2,3-d]pyrimidine-4(3Н)-selenones 4a-c were obtained upon treatment with such nucleophile compounds as NaHS(NaHSe) and Lawsan reagent, respectively (Scheme 1). The presence of different reaction centres in thieno-[2,3-d]pyrimidines 1a-c and 3,4a-c made possible to obtain a number of new potential biologically ac-tive compounds. The alkylation of the starting com-pounds 1a-c was studied at 50-70°C in the presence of alkali (Scheme 2). The acidity of the NH group un-der these conditions provided the easy formation of the anion, which underwent alkylation. Since substance 3а-с can exist in the form of thi-ole and thione, the formation of both S- and N- deri-vatives could be expected depending on the reaction conditions. Thus, when pyrimidine-4(3H)-thiones 3a-c 
are refluxed with NaOH and the corresponding deriva-tives of chloroacetic acid in ethanol, S-substituted de-rivatives are supposed to be obtained. However, the use of NaHCO3 and DMF as a solvent did not lead to formation of N-substituted derivatives as it was ex-pected. It was found that the alkylation occurred at the more nucleophilic sulphur atom in both cas-
es (Scheme 3). All the final products were isolated as crystalline substances with a high melting point (Table 4). The structures of the compounds obtained were confirmed by IR- and NMR 1H spectroscopy (Table 5).The formation of the energetically preferable ar-
omatic system was confirmed by the chemical shift of the signal of protons of the -CH group (8.7-8.9 ppm) in 1H NMR spectra compared to the basic values. In the case of N-alkylation such an effect could not be observed.All the compounds synthesized were screened for their antimicrobial and antifungal activities. The re-sults of the antimicrobial screening by the stiff plate agar diffusion method are given in Table 1. The re-sults of the antimicrobial and antifungal screening by the serial dilution method are presented in Table 2 and 3. Substances that did not reveal the antimicro-bial and antifungal activity were not included in Tab-
les. According to the stiff plate agar diffusion method compounds 4a and 4c revealed a significant activity against E. coli, S. aureus, and M. luteum appeared to be sensitive only to compound 10a.The best fungistatic indicators against A. niger were estimated for substances 4a and 9a. The diame-ter of the inhibition zones of the microbial growth for compound 4a was 22.0 and 12.0 mm in the concen-trations of 0.5 and 0.1%, respectively. MIC of 4a and 
9a were 31.2 µg/mL.
Scheme 1. The synthesis of key precursors 1a-c-4a-b.  
When: a – R’-R’’= -(CH2)4-; b – R’-R’’= -(CH2)3-; c – R’=R’’=CH3.
Scheme 2. Alkylation of compounds 1a-c.  
When: 1a – R’=R’’= -(CH2)4-; 1b – R’=R’’= -(CH2)3-; 1c – R’=R’’=CH3; 
5a – R’=R’’= -(CH2)4-, R’’’= -CH2-CO-OC2H5; 5b – R’=R’’= -(CH2)3-,  
R’’’= -CH2-CO-OC2H5; 5c – R’=R’’=CH3, -CH2-CO-OC2H5;  
6a – R’=R’’= -(CH2)4-, R’’’= -CH2-CO-NH-SO2-C6H4-Cl;  
6b – R’=R’’= -(CH2)3-, R’’’= -CH2-CO-NH-SO2-C6H4-Cl;  
6c – R’=R’’=CH3, -CH2-CO-NH-SO2-C6H4-Cl; 7a – R’=R’’=-(CH2)4-, 
R’’’= (5-isopropyl-1,3,4-thiadiazol-2-yl)-2-oxoethyl; 7b – R’=R’’= -(CH2)3-, 
R’’’=(5-isopropyl-1,3,4-thiadiazol-2-yl)-2-oxoethyl; 7c – R’=R’’=CH3, 
R’’’=(5-isopropyl-1,3,4-thiadiazol-2-yl)-2-oxoethyl; 8a – R’=R’’= 
-(CH2)4-, R’’’= -CH2-NH-CO-Ph; 8b – R’=R’’= -(CH2)3-,  
R’’’= -CH2-NH-CO-Ph; 8c – R’=R’’=CH3, R’’’= -CH2-NH-CO-Ph.
Scheme 3. Alkylation of compounds 3a-c-4a.  
When: 3a – R’=R’’= -(CH2)4-, X=S; 3b – R’=R’’= -(CH2)3-, X=S;  
3c – R’=R’’=CH3, X=S; 4a – R’=R’’= -(CH2)4-, X=Se;  
9a – R’=R’’= -(CH2)4-, R’’’= -CH2-CO-OC2H5, X=S; 9b – R’=R’’= -(CH2)3-, 
R’’’= -CH2-CO-OC2H5, X=S; 9c – R’=R’’=CH3, -CH2-CO-OC2H5, X=S;  
10a – R’=R’’= -(CH2)4-, R’’’= -CH2-CO-NH-SO2-C6H4-Cl, X=S;  
10b – R’=R’’= -(CH2)3-, R’’’= -CH2-CO-NH-SO2-C6H4-Cl, X=S;  
10c – R’=R’’=CH3, -CH2-CO-NH-SO2-C6H4-Cl, X=S;  
11a – R’=R’’=-(CH2)4-, R’’’=(5-isopropyl-1,3,4-thiadiazol-2-yl)-
2-oxoethyl, X=S; 11b – R’=R’’=-(CH2)3-, R’’’=(5-isopropyl-1,3,4-
thiadiazol-2-yl)-2-oxoethyl, X=S; 11c – R’=R’’=CH3, R’’’=(5-isopropyl-
1,3,4-thiadiazol-2-yl)-2-oxoethyl, X=S; 12a – R’=R’’= -(CH2)4-, X=Se; 
R’’’= -CH2-CO-NH-SO2-C6H4-Cl; 12b – R’=R’’= -(CH2)4-, X=Se, 
R’’’=(5-isopropyl-1,3,4-thiadiazol-2-yl)-2-oxoethyl.




The antimicrobial activity of the compounds synthesized (the stiff plate agar diffusion method)
Compounda) Сoncentration, %
The inhibition zones of the compounds studied (mm)
E. coli S. aureus M. luteum A. niger
1c 0.5 – – 7.0
2c 0.5 – – 8.0
4a
0.5 14.0 (b/a) – 22.0 (f/a)
0.1 – – – 12.0 (f/a)
4c
0.5 14.7 – – –
0.1 10.0 – – –
7с 0.5 – – – –
10a 0.5 – 12.0 17.0 –
a)Compounds 1a, 4b, 5a-7b, 8a-12b in the concentration of 0.5 and 1.0 % did not inhibit bacteria and fungi selected; b/a – bacteriostatic 
action; f/a – fungistatic action; – have not been found.
Table 2
The minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC)  
of the compounds synthesized (serial dilution method)
Compounda)
E. coli S. aureus M. luteum
MIC (µg/mL) MBC (µg/mL) MIC (µg/mL) MBC (µg/mL) MIC (µg/mL) MBC (µg/mL)
1с + + + + 250.0 500.0
4c 500.0 * + + + +
5с + + + + 500.0 *
6с + + + + 500.0 *
7с + + + + 31.2 125.0
10a + + 31.2 125.0 31.2 125.0
11a + + 31.2 62.5 + +
a)Compounds 1a-b, 2a-4b, 5a-b, 6a-b, 7a-b, 8a-9c, 10b-c, 11b-12b did not reveal the antibacterial activity in the concentrations tested;  
b)  + The antibacterial activity was not observed in the concentrations tested; c) * The antibacterial activity was not determined in the 
concentrations tested. 
Table 3
The minimal inhibitory concentration (MIC) and the minimal fungicidal concentration (MFC) of the 
compounds synthesized (serial dilution method)
Compounda)
Candida tenus Aspergillus niger
MIC (µg/mL) MFC (µg/mL) MIC (µg/mL) MFC (µg/mL)
1c 125.0 250.0 125.0 *
3c + + 62.5 250.0
4a + + 31.2 *
5b + + 250.0 500.0
5с + + 500.0 *
6с 125.0 * 500.0 *
8а 250.0 * 500.0 *
9a + + 31.2 *
a)Compounds 1a-b, 2a-3b, 4b-c, 5a, 6a-b, 7a-c, 8b-c, 9b-c, 10a-12b did not reveal the antifungal activity in the concentrations tested;  
b) * The antifungal activity was not determined in the concentrations tested; c) + The antifungal activity was not observed in the concentrations 
tested.




Physicochemical properties of alkylation compounds 5a-12b
Compd
No Yield, % M.p., °C
Found, % Mol. formula
M.w
Calc, %
C H N C H N
5a 77 276 57.52 5.56 9.58 C14H16N2O3S 57.52 5.52 9.58
5b 87 236 56.12 5.10 10.09 C13H14N2O3S 56.10 5.07 10.06
5c 83 281 54.12 5.27 10.50 C12H14N2O3S 54.12 5.30 10.52
6a 81 297 49.36 3.66 9.58 C18H16ClN3O4S 49.37 3.68 9.60
6b 59 251 49.71 3.69 6.82 C17H14ClN3O4S 49.69 3.68 6.82
6c 79 312 48.21 3.36 9.89 C14H16ClN3O4S 48.17 3.33 9.91
7a 71 307 55.68 5.19 14.43 C18H20N4O2S2 55.65 5.19 14.42
7b 67 257 54.52 4.85 14.96 C17H18N4O2S2 54.53 4.84 14.96
7c 86 327 53.05 5.02 15.47 C16H18N4O2S2 53.02 5.01 15.46
8a 68 286 63.74 5.07 12.41 C18H17N3O2S 63.70 5.05 12.38
8b 92 298 61.36 4.85 13.41 C16H15N3O2S 61.32 4.82 13.41
9а 57 231 54.57 5.23 9.11 C14H16N2O2S2 54.52 5.23 9.08
9b 72 245 63.74 5.07 12.41 C13H14N2O2S2 63.70 5.05 12.38
9с 65 261 51.09 5.07 9.93 C12H14N2O2S2 51.04 5.00 9.92
10а 77 279 46.43 3.14 9.59 C17H14СlN3O3S3 46.41 3.21 9.55
11а 69 277 53.20 5.48 13.80 C18H22N4OS3 53.17 5.45 13.78
11b 83 289 52.04 5.14 14.30 C17H20N4OS3 52.01 5.14 14.27
11с 75 269 50.55 5.34 14.75 C16H20N4OS3 50.50 5.30 14.72
12а 68 286 60.82 4.82 11.82 C18H16ClN3O3S2Se 60.82 4.82 11.82
12b 52 256 47.94 4.45 12.38 C18H20ClN4OS2Se 47.89 4.47 12.41
Table 5
The data of IR and 1H NMR spectral of alkylation compounds 5a-12b
Compd IR ATR, cm-1 NH Pyrimidine CH Aliphatic protons Aromatic protons
1 2 3 4 5 6
5a 8.3  (1H, s,CH)
4.77 (2H, s, CH2); 4.17-4.22 (2H, q,  
J=6.95 Hz, CH2); 2.9-2.5 (8H, m, 
4CH2); 1.3 (3H, t, J=6.95 Hz, CH3)
5b 8.3 (1H,s,CH)
4.7 (2H, s, CH2); 4.11-4.12 (2H, q, 
J=6.99 Hz,  CH2); 2.9-2.8 (4H, m, 
2CH2); 2.4-2.3 (2H, m, CH2); 1.17-
1.24 (3H, t, J=6.94 Hz, CH3)
5c 8.3 (1H,s,CH)
4.7 (2H, s, CH2); 4.14-4.18 (2H, q, 
J=7.0 Hz, CH2); 2.37 (6H, s, 2CH3); 
1.18-1.24 (3H, t, J=6.97 Hz, CH3)
6a 12.6 (1H, s, NH) 8.17 (1H, s, CH) 4.69 (2H, s, CH2); 2.74-2-2.68 (4H, m, 2CH2); 1.74-1.66 (4H, m, 2CH2)
7.91 (2H, d, J=8.78 Hz, 
Ar-H); 7.72 (2H, d, 
J=8.42 Hz, Ar-H)
6b 12.6 (1H, s, NH) 8.3 (1H, s, CH) 4.6 (2H, s, CH2); 2.75-2.9 (4H, m, 2CH2); 2.3-2.4 (2H, m, CH2)
7.92 (2H, d,  J=8.74 
Hz, Ar-H); 7.7 (2H, d,  
J=8.79 Hz, Ar-H)
6c 12.6 (1H, s, NH) 8.17 (1H, s, CH) 4.7 (2H, s, CH2); 2.31-2.33 (6H, s, 2CH3)
7.91 (2H, d, J=8.74 
Hz, Ar-H); 7.70 (2H, d, 
J=8.74 Hz, Ar-H)
7a 12.95 (1H, s, NH) 8.3 (1H, s, CH)
4.94 (2H, s, CH2); 2.75-2.82 (5H, 
m, 2CH2); 1.76-1.64 (4H, m, 2CH2); 
1.3 (6H, d, J=6.4 Hz, 2CH3)
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According to the serial dilution method the growth of S. aureus was mostly inhibited by compounds 10a and 
11a in the concentrations of 31.2 μg/mL. E. coli appeared to be almost insensitive to the compounds synthesized in the concentrations tested. Only compounds 4c revealed a weak inhibitory activity against it (MIC = 500.0 µg/mL). Compounds 7c and 10a had the moderate antibacterial activity against M. luteum (MIC = 31.2 µg/mL). 
Experimental Part
Chemical PartThe 1H NMR spectra were recorded in DMSO-d6 on a Varian Mercury VX-200 instrument (200 MHz). The internal standard for the NMR spectra was TMS. IR spec-tra (4000-600 cm-1) were recorded on a Bruker ALPHA 
FTIR spectrometer using a module for measuring at-
tenuated total reflection (ATR) on a Bruker Tensor 27 spectrometer (KBr) and expressed in cm-1. The mass spectra were recorded on a Varian 1200L instrument with direct injection of the sample at 250°C and 70eV ionizing electrons. Elemental analysis was performed on an LECO CHNS-900 instrument. Melting points were determined in open capillary tubes and were uncor-rected. The reaction and the purity of the compounds obtained were monitored by TLC on Merck Silicagel 60 F-254 plates with 10:1 CHCl3-2-PrOH as an eluent.Compounds 1a-c and 2a-c were synthesized by the method described in the literature [7, 8].
5,6-Dimethylthieno[2,3-d]pyrimidin-4(3H)-
one 1c: A white powder. M.p. –268°С. yield – 90%; 
1 2 3 4 5 6
7b 12.96 (1H, s, NH) 8.3 (1H, s, CH)
4.96 (2H, s, CH2); 2.72-2.88 (5H, 
m, 2CH2); 2.35-2.4 (2H, m, CH2); 
1.31 (6H, d, J=6.49 Hz, 2CH3)
7c 12.94 (1H, s, NH) 8.3 (1H, s, CH)
4.94 (2H, s, CH2); 2.35 (6H, s, 
2CH3); 1.32 (6H, d, J=6.51 Hz, 
2CH3)
8a 9.6 (1H, br s, NH) 8.48 (1H, s, CH)
5.4 (2H, d, J=6.58 Hz, CH2); 2.72-
2.88 (4H, m, 2CH2); 1.7-1.83 (4H, 
m, 2CH2)
7.88 (2H, m, Ar-H);  
7.5 (3H, m, Ar-H)
8b 9.39 (1H, br s, NH) 7.98 (1H, s, CH) 4.7 (2H, d, J=6.56 Hz, CH2); 2.34 (6H, s, 2CH3)
7.8 (2H, m, Ar-H);  
7.5 (3H, m, Ar-H)
9a
2985, 2937, 2857, 
2751, 2674, 1413, 
1257, 1071, 809, 
732
8.65 (1H, s, CH)
4.16-4.14 (4H, m, 2CH2); 2.8-3.0 
(4H, m, 2CH2); 1.6-1.83 (4H, m, 
2CH2); 1.14-1.21 (3H, t, J=6.99 Hz, 
CH3)
9b
2999, 2974, 2908, 
2853, 1744, 1667, 
1452, 1175, 1086, 
853, 781, 742
8.3 (1H, s, CH);
4.79 (2H, s, CH2); 4.14-4.19 (2H, q, 
J=7.12 Hz, CH2); 2.9-3.07 (4H, m, 
2CH2); 2.37-2.42 (2H, m, CH2); 1.1 
(3H, t, J=6.95 Hz, CH3)
9c
2978, 2908, 2860, 
1738, 1535, 1166, 
882, 629
8.63 (1H, s, CH)
4.03-4.13 (4H, m, 2CH2); 2.44 (6H, 
s, 2CH3); 1.11-1.18 (3H, t, J=6.99 
Hz, CH3)
10а 12.3 (1H, s, NH) 8.5 (1H, s, CH) 4.1 (2H, s, CH2); 3.0-3.2 (4H, m, 2CH2); 2.1-2.3 (2H, m, CH2)
7.8 (3H, m, CHar);  
7.4 (2H, m, CHar)
11а 12.6 (1H, s, NH) 7.94 (1H, s, CH)
4.37 (2H, s, CH2); 2.77-2.88 (4H, 
m, 2CH2); 2.0-2.06 (5H, m, 2CH2); 
1.3 (6H, d, J=6.99 Hz, 2CH3)
11b
2964, 2931, 2901, 
2858, 1461, 1235, 
829, 749
12.9 (1H, s, NH) 8.66 (1H, s, CH)
4.4 (2H, s, CH2); 3.04-3.10 (7H, 
m, 3CH2); 1.3 (6H, d, J=6.59 Hz, 
2CH3)
11с
3047, 2984, 2821, 
2705, 1518, 1236, 
924, 838
12.8 (1H, br s, NH) 8.38 (1H, s, CH)
4.38 (2H, s, CH2); 2.55 (6H, s, 
2CH3); 1.3 (6H, d, J=6.99 Hz, 
2CH3)
12а 12.5 (1H, s, NH) 8.4 (1H, s, CH) 4.07 (2H, s, CH2); 2.82-2.92 (4H, m, 2CH2); 1.74-1.83 (4H, m, 2CH2)
7.9 (2H, d, J=8.78 Hz, 
Ar-H); 7.5 (2H, d,  
J=8.42 Hz, Ar-H)
12b
2929, 2867, 2834, 
2696, 1408, 1316, 
1152, 1076, 769, 
618
12.75 (1H, s, NH) 8.66 (1H, s, CH)
4.36 (2H, s, CH2); 2.82-2.98 (5H, 
m, 2CH2); 1.8-1.7 (4H, m, 2CH2); 
1.1 (6H, d, J=6.62 Hz, 2CH3)
Continuation Table 5
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1H NMR: 12.3 (1H, br s, N-H). 8.0 (1H, br s, =C-H), 2.31 (3H, s, CH3), 2.34 (3H, s, CH3); Found, %: C 53.33; H 
4.47; N 15.54. C8H8N2OS. Calculated, %: C 53.31; H 
4.47; N 15.54.
The general procedure of the synthesis of com-
pounds 2a-c: Dissolve compounds 1a-c (12 g) in phosphorus oxychloride, and then add gradually di-methylaniline 14 ml (0.11 Mol). Heat the reaction mixture for 4 h, evaporate the excess of phosphorous oxychloride under reduced pressure, neutralize the solid residue was with 5% aq Na2CO3 solution. Filter the precipitate formed and recrystallize from toluene. 
4-Chloro-5,6-dimethylthieno[2,3-d]pyrimidi-
ne 2c: a light yellow powder, yield – 96%, calculated for the structure proposed. M.p. – 117°С. This inter-mediate chlorpyrimidine was used at the next step 
without purification. 
The general procedure of the synthesis of com-
pound 3a-c – method A: Dissolve compounds 2a-c (0.0084 Mol) in DMF, add the solution of sodium hydro-
sulfide (1 g, 0.0179 Mol). Stir the mixture obtained for 24 h at room temperature, adjust pH to ~7.0 with aq NaOH solution (15 mL). Add hydrochloric acid to 
the filtrate and recrystallize the white precipitate ob-tained from CH3CN.
Method B: Reflux the mixture of compounds 2a-c (0.0084 Mol) and the Lawsan reagent (0.0084 Mol) 
in 15 mL of 1,4-dioxan for 6 h and filter hot. Recrys-tallize the precipitate obtained from CH3CN.
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyri-
midine-4(3H)-thione (3a): A yellow powder. Yield – 75%. M.p. – 213°С; 1H NMR: 13.5 (1H, br s, NH). 8.0 (1H, br s, CH), 2.8-2.9 (4H, m, 2CH2), 1.6-1.9 (4H, m, 2CH2). MS: m/z (I,%) – 222 (96%) [M]+. Found, %: C 
54.05; H 4.52; N 12.60. C10H10N2S2. Calculated, %: C 
54.02; H 4.53; N 12.60.
3,5,6,7-Tetrahydro-4H-cyclopenta[4,5]thie-
no[2,3-d]pyrimidine-4-thione (3b): A yellow powder. Yield – 60%. M.p. – 223-224°С; 1H NMR: 12.6 (1H, 
br s, N-H). 7.9 (1H, br s, C-H), 2.9-3.0 (2H, m, CH2), 2.0-2.2 (4H, m, 2CH2); MS: m/z (I,%) – 208 (77%) [M]+. Found, %:  C 51.91; H 3.87; N 13.45. C9H8N2S2. 
Calculated, %: C 51.90; H 3.87; N 13.45; 
5,6-Dimethylthieno[2,3-d]pyrimidine-4(3H)-
thione (3c): A yellow powder. Yield – 62%. M.p. – 239-240°С; 1H NMR: 13.0 (1H, br s, NH). 8.4 (1H, br s, CH), 2.1 (3H, s, CH3), 2.4 (3H, s, CH3). MS: m/z (I,%) – 208 (77%) [M]+. Found, %: C 48.95; H 4.11; N 14.25. C8H8N2S2. Cal-
culated, %: C 48.95; H 4.11; N 14.27. 
The general procedure of the synthesis of com-
pound 4a-c: Add selenium (0.0012 Mol) gradually to absolute ethanol (50 mL) with stirring on an ice bath. After that gradually add sodium hydroborate 0.4 g (0.0032 Mol) to the solution for 15 min. Stir the re-sulting mixture for 1.5 h until selenium is complete-ly dissolved. Dissolve compounds 2a-c in ethanol, cool and add to the solution of sodium hydroselenide. 
Stir the reaction mixture under nitrogen for 3 h. Then pour the solution into the mixture of hydrochloric 
acid (100 mL) аnd ice (50 mL). Filter the precipitate formed and recrystallize from aq MeOH.
5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyri-
midine-4(3H)-selenone (4a): A yellow powder. Yield – 65%. M.p. – 190°С; 1H NMR: 12.9 (1H, s, NH); 8.1 (1H, s, CH); 4.6 (2H, s, CH2); 2.8-3.0 (4H, m, 2CH2). 
Found, %: C 44.62; H 3.76; N 10.42. C10H10N2SSe. Cal-
culated, %: C 44.61; H 3.74; N 10.41. 
5,6-Dimethylthieno[2,3-d]pyrimidine-4(3H)-se-
lenone (4c): A yellow powder. Yield – 55%. M.p. – 200°С; IR (ATR, cm-1): 3116, 3036, 2965, 2910, 2840, 2766, 1679, 1563, 1485, 1406, 1352, 1294, 1212, 1144, 1040, 
925, 812, 705, 604. 1H NMR: 13.1 (1H, s, NH); 8.0 (1H, s, CH); 2.9 (3H, s, CH3); 2.2 (3H, s, CH3). MS: m/z (I,%) – 243 (85%) [M]+. Found, %: C 39.51; H 3.34; N 11.54. C8H8N2SSe. Calculated, %: C 39.51; H 3.32; N 11.52.
The general procedure of alkylation of com-
pounds 1a-c: To the suspension of compound 1a-c (0.0044 Mol) in ethanol (5 ml) add 0.1 g (0.0044 Mol) of sodium hydroxide and heat for 10 min. When com-pounds are dissolved, add the corresponding alkyla-
ting agent (0.0044 Mol), and reflux the mixture for 
30-40 min at 70°С. Filter the precipitate formed and recrystallize from aq MeOH. The general procedure of alkylation of compounds 
3a-c – method A: Heat the mixture of compounds 
3a-c (0.0044 Mol) and potassium carbonate 0.8 g (0.0061 Mol) in DMF (5 ml) at 40°C for 5 min. Then add the corresponding alkylhalogenide (0.0044 Mol). Stir the reaction mixture at 40°C for 24 h and pour into water. Filter the precipitate formed, dry and re-crystallize from EtOH. 
Method B: Add while stirring the solution of com-pounds 3a-c (0.0044 Mol) in ethanol (5 ml) to 0.2 g (0.0057 Mol) of the solution of sodium hydroxide in ethanol (3 ml). Then add the corresponding alkylhaloge-
nide (0.0044 Mol) and reflux at 70°С for 30 min. Cool 
the reaction mixture, filter the precipitate formed, dry and recrystallize from CH3CN. 
The general procedure of alkylation of com-
pounds 4a-b: Add while stirring the solution of com-pounds 4a-c (0.0044 Mol) in ethanol (5 ml) to the so-lution of sodium hydroxide (0.0057 Mol) in ethanol (3 ml). Then add the corresponding alkylhalogenide 
(0.0044 Mol) and reflux at 70°С for 30 min. Cool the 
reaction mixture, filter the precipitate formed, dry and recrystallize from CH3CN. 
Biological Assay Antimicrobial and antifungal test 1) Stiff plate agar diffusion method. The study of the antimicrobial and antifungal activity of the com-pounds synthesized was carried out using the stiff plate agar diffusion method against E. coli, S. aureus, 
M. luteum, C. tenuis and A. niger [6]. The amount of 
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ISSN 2308-8303microbial cells was 109 c.f.u./mL. The incubation pe-riod for bacteria was 24 h at 35°C, for fungi – 48-72 h at 28-30°C. Antibiotics vancomicin, oxacillin, nysta-tin were used as standards. The bacterial cultures, standards and the substances obtained were applied across grooves in the concentration of 5 mg/mL, and then allowed to diffuse in the agar nutrient plate. The antimicrobial effect and the degree of activity of the compounds tested were evaluated by measuring of 
diameters of the inhibition zones (insensitive: 11-15 mm; 
sensitive: 16-25 mm; highly sensitive >25 mm). All experiments were repeated three times.2) Serial dilution method. The minimal inhibi-tory concentration (MIC) was determined using serial dilutions in the liquid nutrient medium by the classical method [7]. Innoculations were made in the meat infu-sion broth at pH 7.0 for bacteria or in the wort agar for fungi with different concentrations of the compounds tested. The amount of microbial cells was 109 c.f.u./mL. Results were calculated after storing the control and test tubes for 24-72 h (at 37°C for bacteria and at 30°C for fungi) by determining the presence or ab-sence of microbial growth in the medium contain-ing various dilutions of the compound tested. The last tube with growth inhibition (transparent broth) was considered to be the MIC of the compound against the given strain.In the test tubes 0.02 mL of the transparent me-dium was innoculated in the sterilized meat infusion broth (for bacteria) or the wort agar (for fungi) in a stiff plate. The incubation period for bacteria was 24 h at 35°C, for fungi – 48-72 h at 28-30°C. The minimal 
bactericidal concentration (MBC) and the minimal fungicidal concentration (MFC) were calculated by the absence of the colony growth. All experiments were repeated three times. 
ConclusionsThe aim of the present study was to synthesize and investigate the antibacterial and antifungal activi- ties of some new thienopyrimidine derivatives. The starting material 1 (R1,R2-thieno[2,3-d]pyrimidine-4(3H)-one) was used to synthesize the correspond-ing thiones and selenones. The reaction of alkylation of the compounds obtained was studied. In the case of thieno[2,3-d]pyrimidine-4(3H)-ones the products of N-alkylation were obtained. When thieno[2,3-d]pyrimidine-4(3H)-thio(seleno)nes were alkylated, S- and Se- derivatives were obtained. Changing of the reaction conditions did not lead to N-alkylated pro- ducts as it was expected. The antibacterial and antifungal activities of the compounds obtained in vitro have been screened using the stiff plate agar diffusion method and the serial di-lution method. According to the stiff plate agar dif-fusion method compounds 4a and 4c have revealed 
a significant activity against Escherichia coli, S. au-
reus, and M. luteum appeared to be the most sensi-tive to compound 10a in the concentration of 0.5%, 
it has also been confirmed by the serial dilution 
method (MIC 1=31.2 µg/mL; MBC =125 µg/mL for 
M. luteum). The best fungistatic indicators against 
A.niger have been found for compounds 4a and 9a (MIC = 31.2 µg/mL).
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